The revenue of the company for the quarter under review stood at Rs 868 crore as compared to Rs 782 crore a year ago which ...

Cyient Shares nosedived on NSE (National Stock Exchage) to new 52 week low level of Rs 1,404.15 after comapny declared their ...

Jefferies said that Dr Reddy's weakness in core profitability showed up in the Q3 numbers. The company also faced incremental ...

The share price of Indus Towers has fallen 0.3% in the past five trading days. It has risen more than 11% in the past one ...

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, ...

The wearable device, created by the San Francisco-based startup Based Hardware, offers versatility in how it can be used. It ...

Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs 1,413 crore. Despite robust revenue growth, Jefferies, Nuvama, and DAM ...

Kalpataru Projects International added 1.46% to Rs 1121.40 after the company said that it has secured new orders/notification of awards of Rs 2,038 crore.

Dr Reddy’s share prices dropped today as brokerages cut targets due to weak US and India performance. Explore the financial outlook now!

In the third quarter, the heavyweight natural gas company is expected to record lower EBITDA owing to gas trading margin. High LNG prices are likely to impact domestic gas demand. Despite this, there ...

Indus Towers saw its revenue from operations rise by 4.8 percent, reaching Rs 7,547 crore, up from Rs 7,199 crore in the ...